Related Experiment Video
Updated: Jun 15, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Community acquired pneumonia in children].
Faten Tinsa1, Khadija Boussetta, Ahmed Gharbi
1Service de Médecine Infantile B, Hôpital d'Enfants de Tunis, Tunis, Tunisie.
La Tunisie Medicale
|March 10, 2010
Summary
Community acquired pneumonia in children often lacks easy etiological diagnosis. Mycoplasma pneumoniae was frequently identified, highlighting the need for improved diagnostic methods in pediatric pneumonia.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Clinical Medicine
Context:
- Community acquired pneumonia (CAP) presents a significant health challenge in children, often with diagnostic difficulties.
- Current etiological diagnosis for pediatric CAP is complex, leading to probabilistic treatment strategies.
Purpose:
- To analyze clinical patterns and outcomes of pediatric CAP.
- To identify factors associated with the origin of pediatric pneumonia.
Summary:
- A prospective study analyzed 39 children hospitalized for CAP, identifying causative agents in 41% of cases.
- Mycoplasma pneumoniae was the most common pathogen, followed by Streptococcus pneumoniae and Haemophilus influenzae.
- Bacterial pneumonia was linked to persistent cough, while Mycoplasma pneumoniae correlated with high fever and dry cough. C-reactive protein levels showed moderate predictive value.
Impact:
- The findings underscore the need for enhanced microbiological techniques to accurately diagnose pediatric pneumonia.
- Mycoplasma pneumoniae appears to be a prevalent pathogen in preschool-aged children with CAP.
Related Concept Videos
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: